QbD Group

QbD Group is a consulting and services group that works with pharmaceutical, biotech, medical device and in vitro diagnostics companies across the full product lifecycle, from development through market access and post-market compliance. Its technical work spans qualification and validation, quality assurance, regulatory affairs, clinical solutions, laboratory services, vigilance, software solutions and toxicology. The firm pairs advisory work with hands-on execution, placing consultants directly into client teams.

The group employs over 600 professionals and reports a client base of more than 1,200 worldwide, with operations across multiple international locations. Its customers range from early-stage startups to large global companies in regulated industries.

Alongside the core practice, QbD Group operates several specialised subsidiaries. Qarad focuses on in vitro diagnostics, Quercus provides GMP laboratory services, and Scilife develops quality management software. The QbD Group Foundation extends the firm's activity beyond commercial work, funding scientific research, environmental initiatives and health projects.

Engagements emphasise proactive risk management, on-time delivery and adherence to compliance standards in regulated environments. The stated aim of the work is to bring innovations to patients faster and more safely.